Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: June 28, 2017
What are the generic sources for quinapril hydrochloride and what is the scope of quinapril hydrochloride freedom to operate?
Quinapril hydrochloride is the generic ingredient in two branded drugs marketed by Sun Pharm Inds Ltd, Sandoz, Teva, Prinston Inc, Aurobindo Pharma Ltd, Mylan, Apotex Inc, Actavis Labs Fl Inc, Invagen Pharms, Actavis Elizabeth, Pfizer Pharms, and Lupin, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.| Tradenames: | 2 |
| Patents: | 1 |
| Applicants: | 12 |
| NDAs: | 14 |
| Drug Master File Entries: see list | 11 |
| Suppliers / Packagers: see list | 21 |
| Bulk Api Vendors: see list | 34 |
| Clinical Trials: see list | 2,263 |
| Patent Applications: see list | 2,088 |
| Therapeutic Class: | Cardiovascular Agents |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see low prices |
| DailyMed Link: | quinapril hydrochloride at DailyMed |
| Drug Class | Angiotensin Converting Enzyme Inhibitor |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Applicant | Application No. | Strength | Dosage Form |
| ► Subscribe | ► Subscribe | EQ 5MG BASE | TABLET;ORAL |
| ► Subscribe | ► Subscribe | EQ 40MG BASE | TABLET;ORAL |
| ► Subscribe | ► Subscribe | EQ 20MG BASE | TABLET;ORAL |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076049-003 | Jan 14, 2005 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Aurobindo Pharma Ltd | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 202725-003 | Apr 29, 2013 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
Actavis Elizabeth | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076459-004 | Dec 22, 2004 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Mylan | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 076036-001 | Jan 28, 2005 | DISCN | No | No | ► Subscribe | ► Subscribe | |||||||||||||||||||
Invagen Pharms | QUINAPRIL HYDROCHLORIDE | quinapril hydrochloride | TABLET;ORAL | 078457-003 | Aug 24, 2007 | AB | RX | No | No | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-004 | Nov 19, 1991 | 4,743,450*PED | ► Subscribe | ||||||||||||||||||||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-004 | Nov 19, 1991 | 5,684,016*PED | ► Subscribe | ||||||||||||||||||||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-001 | Nov 19, 1991 | 5,747,504*PED | ► Subscribe | ||||||||||||||||||||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-003 | Nov 19, 1991 | 5,684,016*PED | ► Subscribe | ||||||||||||||||||||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-002 | Nov 19, 1991 | 4,743,450*PED | ► Subscribe | ||||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
Join the 21,731 other biopharmaceutical professionals who get our Drug Patent Expiration Alerts:
